The effects and underlying mechanisms of S-allyl l-cysteine treatment of the retina after ischemia/reperfusion

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 2, 2012, Pages 110-117

  Chen, Yan Qing ^a,b,c   Pan, Wynn H T ^c   Liu, Jorn Hon ^b   Chen, Mi Mi ^b   Liu, Chi Ming ^b,c   Yeh, Ming Yang ^b   Tsai, Shen Kou ^b   Young, Mason Shing ^b   Zhang, Xiu Mei ^a   Chao, Hsiao Ming ^b,c  

^a SHANDONG UNIVERSITY   (China)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE ACETYLTRANSFERASE; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; S ALLYLCYSTEINE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; MOLECULAR BIOLOGY; NONHUMAN; OXIDATIVE STRESS; PROTEIN DETERMINATION; RAT; REPERFUSION INJURY; RETINA AMACRINE CELL; RETINA GANGLION CELL; RETINA ISCHEMIA; RNA ANALYSIS; SINGLE DRUG DOSE;

ANIMALS; ANTIOXIDANTS; CELL LINE; CYSTEINE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTRAOCULAR PRESSURE; ISCHEMIA; MATRIX METALLOPROTEINASE 9; OXIDATIVE STRESS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; RETINA; RNA, MESSENGER; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84859377837     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0099     Document Type: Article

References (20)

1. Chao, H.M., Lin, D.E., Chang, Y., et al. Ferulic acid, but not tetramethylpyrazine, significantly attenuates retinal ische-mia/reperfusion- induced alterations by acting as a hydroxyl radical scavenger. J. Ocul. Pharmacol. Ther. 24:461-472, 2008.
2. Osborne, N.N., Ugarte, M., Chao, H.M., et al. Neuropro-tection in relation to retinal ischemia and relevance to glaucoma. Surv. Ophthalmol. 43(Suppl. 1):S102-S128, 1999. (Pubitemid 29328586)
3. Peng, Y.W., Blackstone, C.D., Huganir, R.L., et al. Distribution of glutamate receptor subtypes in the vertebrate retina. Neuroscience 66:483-497, 1995.
4. Zarbin, M.A. Current concepts in the pathogenesis of age related macular degeneration. Arch. Ophthalmol. 122:598-614, 2004. (Pubitemid 38456297)
5. Hakansson, G., Gesslein, B., Gustafsson, L.L., et al. Hypoxia-inducible factor and vascular endothelial growth factor in the neuroretina and retinal blood vessels after retinal ischemia. J. Ocul. Biol. Dis. Inform. 3:20-29, 2010.
6. Hiroaki, O., Aimee, Y.Y., Neil, D., et al. Hypoxia inducible factor-1a is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest. Ophthalmol. Vis. Sci. 40:182-189, 1999.
7. Aktas, Z., Gurelik, G., Göcün, P.U., et al. Matrix metallo-proteinase-9 expression in retinal ganglion cell layer and effect of topically applied brimonidine tartrate 0.2% therapy on this expression in an endothelin-1-induced optic nerve ischemia model. Int. Ophthalmol. 30:253-259, 2010.
8. Guo, L., Moss, S.E., Alexander, R.A., et al. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest. Ophthalmol. Vis. Sci. 46:175-182, 2005. (Pubitemid 40041195)
9. Zhang, X., Cheng, M., and Chintala, S.K. Optic nerve ligation leads to astrocyte-associated matrix metalloproteinase-9 induction in the mouse retina. Neurosci. Lett. 356:140-144, 2004. (Pubitemid 38121488)
10. 2-induced oxidative stress by scavenging reactive oxygen species and down-regulating the expression of matrix metalloproteinase-9 and vascular endothelial growth factor. J. Ocul. Pharmacol. Ther. 26:421-429, 2010.
11. Kim, K.M., Chun, S.B., Koo, M.S., et al. Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl L-cysteine. Free Radic. Biol. Med. 30:747-756, 2001.
12. Krishnamoorthy, R.R., Agarwal, P., Prasanna, G., et al. Characterization of a transformed rat retinal ganglion cell line. Brain Res. Mol. Brain Res. 86:1-12, 2001. (Pubitemid 32124753)
13. Van Bergen, N.J., Wood, J.P., Chidlow, G., et al. Recharacterization of the RGC-5 retinal ganglion cell line. Invest. Ophthalmol. Vis. Sci. 50:4267-4272, 2009.
14. Kim, K.M., Lee, J.C., Chang, N., et al. S-allyl L-cysteine attenuates cerebral ischemic injury by scavenging peroxyni-trite and inhibiting the activity of extracellular signal-regulated kinase. Free Radic. Res. 40:827-835, 2006. (Pubitemid 44480493)
15. Fahim, A., Seema, Y., and Sandeep, K.A. S-allyl L-cysteine diminishes cerebral ischemia-induced mitochondrial dysfunctions in hippocampus. Brain Res. 1265:128-137, 2009.
16. He, S., and Masland, R.H. Retinal direction selectivity after targeted laser ablation of starburst amacrine cell. Nature 389:378-382, 1997. (Pubitemid 27415218)
17. Dong, W., Sun, W., Zhang, Y., et al. Dendritic relationship between starburst amacrine cells and direction-selective ganglion cells in the rabbit retina. J. Physiol. 556(Pt 1):11-17, 2004. (Pubitemid 38515165)
18. Kosuge, Y., Sakikubo, T., Ishige, K., et al. Comparative study of endoplasmic reticulum stress-induced neuronal death in rat cultured hippocampal and cerebellar granule neurons. Neurochem. Int. 49:285-293, 2006. (Pubitemid 43975193)
19. Ray, B., Chauhan, N.B., and Lahiri, D.K. Oxidative insults to neurons and synapse are prevented by Aged Garlic Extract (AGE) and S-allyl L-cysteine (SAC) treatment in the PC12 neuronal culture and APP-Tg mouse model. J. Neurochem. 117:388-402, 2011.
20. Ray, B., Chauhan, N.B., and Lahiri, D.K. The "aged garlic extract:" (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's Disease (AD). Curr. Med. Chem. 18:3306-3313, 2011.